A detailed history of E Fund Management Co., Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 37,786 shares of PFE stock, worth $1.05 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
37,786
Previous 13,922 171.41%
Holding current value
$1.05 Million
Previous $400,000 162.0%
% of portfolio
0.07%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $617,838 - $709,476
23,864 Added 171.41%
37,786 $1.05 Million
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $65,690 - $85,325
2,514 Added 22.04%
13,922 $400,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $13,509 - $15,791
-421 Reduced 3.56%
11,408 $378,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $38,829 - $44,924
-1,075 Reduced 8.33%
11,829 $434,000
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $1,378 - $1,794
-35 Reduced 0.27%
12,904 $526,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $48,096 - $62,784
-1,152 Reduced 8.18%
12,939 $663,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $42,534 - $51,924
972 Added 7.41%
14,091 $617,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1,488 - $1,765
32 Added 0.24%
13,119 $688,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $73,977 - $91,667
-1,617 Reduced 11.0%
13,087 $678,000
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $18,965 - $28,113
-459 Reduced 3.03%
14,704 $868,000
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $101,108 - $129,881
2,576 Added 20.47%
15,163 $652,000
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $421,538 - $475,410
12,587 New
12,587 $456,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.